- Tytuł:
- Rationale and Design of a Phase II Trial of Combined Serplulimab and Chemotherapy in Patients with Histologically Transformed Small Cell Lung Cancer: a Prospective, Single-arm and Multicentre Study
- Autorzy:
- Źródło:
- In Clinical Oncology January 2024 36(1):39-45
Czasopismo naukowe